Sign Up for Free!

Continue Analyzing the page and more.

Already have an Account? Log In

The Trial has ended

Continue Analyzing the page and more.

Kraig Biocraft Laboratories, Inc logo
KBLB

Kraig Biocraft Laboratories, Inc

MaveScore 34 Low model confidence
Last Price US$0.10 As of Jul 10, 2026
Market Cap US$120.0m Company size context
7D Performance -4.73% Past 7 days
1Y Performance 27.80% Past 12 months
Model Rating
Historical model output for research review

Fundamental data date

Mar 31, 2026

102 days old

Market price date

Jul 10, 2026

1 day old

Coverage

15/16

1 missing model inputs

Data quality

Excellent

Current stored snapshot

Transparent research score

Why the model scores this stock

MaveScore is a research prioritization score from 0 to 100. It is historical model output for watchlist review, not personalized financial advice.

MaveScore 34 Low confidence

Stored data quality

Freshness and coverage checks

15/16 Current stored snapshot

Quality

9/35 Weak

Blends latest model rank with profitability and dilution ranks.

Financial Strength

12/25 Mixed

Rewards durable profitability, margins, and positive free cash flow.

Valuation Support

8/15 Mixed

Favors positive earnings, positive cash flow, and lower multiples.

Momentum

5/15 Weak

Highlights research candidates with supportive 3-month and 6-month price regimes.

Shareholder Alignment

0/10 Weak

Rewards less dilutive share behavior and enough size for liquid research coverage.

Positive model output

More live company inputs are needed before positive research signals can be surfaced.

Research risks to review

  • Blends latest model rank with profitability and dilution ranks.
  • Highlights research candidates with supportive 3-month and 6-month price regimes.
  • Rewards less dilutive share behavior and enough size for liquid research coverage.

MaveScore uses historical model inputs, stored company fundamentals, and stored price context for research support only. Review missing inputs and business-specific risks before acting. Missing inputs right now include free cash flow per share.

Dashboard Funda..tals Prediction Screener Map

Kraig Biocraft Laboratories, Inc Overview

Industry: Specialty Chemicals

Sector: Basic Materials

Kraig Biocraft Laboratories, Inc. engages in developing protein-based fibers using recombinant DNA technology for commercial applications in the technical textile and specialty fiber industries in the United States. Its primary proprietary fiber technology includes natural and engineered variants of spider silk produced in domesticated mulberry silkworms, as well as uses genetically engineered silkworms that produce spider silk proteins to create its recombinant spider silk. The company's products are used in military and police, and defense applications for ballistic protection; industrial applications, including critical cables and abrasion/impact resistant components; safety equipment; and composite materials for the aero-space industry. Its products are also used in various markets, such as medical textiles, geotextiles, defense and military textiles, safe and protective clothing, filtration textiles, composites with textile structure, and functional and sportive textiles, as well as textiles used in buildings and transportation. Kraig Biocraft Laboratories, Inc. was incorporated in 2006 and is headquartered in Ann Arbor, Michigan. Kraig Biocraft Laboratories, Inc. engages in developing protein-based fibers using recombinant DNA technology for commercial applications in the technical textile and specialty fiber industries in the United States. Its primary proprietary fiber technology includes natural and engineered variants of Read More

Kraig Biocraft Laboratories, Inc is evaluated based on the investment philosophy and approach to stock market investing developed by renowned investor Warren Buffett. Companies with high ratings typically exhibit growing earnings, a substantial profit margin, conservative leverage, a consistently high return on equity, and a sustained practice of repurchasing their shares over the years.

Kraig Biocraft Laboratories, Inc

Score

Reported Results

What the company reported, with filing details kept small.

Filed May 14, 2026

Quarterly result summary

Latest company-filed earnings material is available for source review.

What changed

  • Review the SEC source filing for the full reported results and management commentary.

Guidance / outlook

No formal outlook was extracted from this filing excerpt. Open the SEC source to review full management commentary.

SEC filing Open filing

Source: SEC EDGAR company-filed earnings materials. Dates are shown only for verification; review the source filing before relying on extracted report details.

Other recent earnings materials

Recent News



Earnings Per Share

Score 1.00/5
Kraig Biocraft Laboratories, Inc earns a low score, as its Earnings Per Share (EPS) has not shown continuous growth over the last six years. Notable counterparts in the sector with high scores includes Linde PLC NEWMARKET CORP Sherwin-Williams Co
In Specialty Chemicals industry , Linde PLC , NEWMARKET CORP , Sherwin-Williams Co are companies with high ratings.

Return on Equity

Score 1.79/5
Kraig Biocraft Laboratories, Inc exhibits a lower score in the Return on Equity (ROE) section, falling below the sector median value and indicating a comparatively weaker performance in this metric. The top companies in the same sector include Linde PLC NEWMARKET CORP Sherwin-Williams Co
Kraig Biocra... KBLB US$120.0m
Linde PLC LIN US$252.9b
NEWMARKET CO... NEU US$7.2b
Sherwin-Will... SHW US$86.9b

Net Margin

Score 2.36/5
Kraig Biocraft Laboratories, Inc olds a low score as its net margin consistently trails below the sector median value and doesn't exhibit continuous growth over the last six years; notable companies in the sector with commendable scores include Linde PLC NEWMARKET CORP Sherwin-Williams Co
Kraig Biocra... KBLB US$120.0m
Linde PLC LIN US$252.9b
NEWMARKET CO... NEU US$7.2b
Sherwin-Will... SHW US$86.9b

Share Buyback

In Specialty Chemicals industry , Linde PLC , NEWMARKET CORP , Sherwin-Williams Co are companies with high ratings.

Leverage

Score 3.00/5
Kraig Biocraft Laboratories, Inc attains a commendable score in the category due to its lower leverage ratio over the past six years in comparison to the sector median value. Additionally, other notable companies in the same sector, such as Linde PLC NEWMARKET CORP Sherwin-Williams Co , also exhibit high scores.
Kraig Biocra... KBLB US$120.0m
Linde PLC LIN US$252.9b
NEWMARKET CO... NEU US$7.2b
Sherwin-Will... SHW US$86.9b

Financial Statements

Company-reported SEC EDGAR facts organized into the three core statements.

SEC financial statements are temporarily unavailable.

Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.

Financial Ratio

Yearly Quarterly

Financial
Profitability
Growth
Cash Flow
Financial Health
Efficiency Ratios

Kraig Biocraft Laboratories, Inc logo

Kraig Biocraft Laboratories, Inc

US$0.10

US$120.0m

-4.73%

27.80%